Your Health. Your Family. Your Choice.
Administered by: Other Purchased by: ?
Life Threatening? Yes
Write-up: Found dead; Myocarditis; Headache; Fever; Appetite lost; This is a spontaneous report from a non-contactable physician downloaded from the Regulatory Agency (A)-WEB, regulatory authority number DE-PEI-202100217297. A 12-year-old Male patient received the second dose of Bnt162b2 (COMIRNATY) on 13Oct2021 at the age of 12-year-old (Lot/Batch: SDCN1) as 0.3 ml single dose for covid-19 immunisation. The patient''s medical history included Distal arthrogryposis, Cardiomyopathy. Concomitant medications were not reported. The patient previously received the first dose of bnt162b2 (COMIRNATY) on 22Sep2021 at the age of 12-year-old as 0.3 ml single dose for covid-19 vaccination/immunisation. On 14Oct2021 the patient experienced Fever, Headache, Appetite lost. On 15Oct2021 the patient experienced Found dead, Myocarditis. This report is serious due to death, life threatening. Relatedness of drug to reaction(s)/event(s): Source of assessment: Agency. Result of Assessment: D. Unclassifiable. Autopsy Done and Results was Available as Cardiac death in cardiomyopathy. The outcome of the event was fatal. No follow-up attempts are possible, no further inforamtion is expected.; Autopsy-determined Cause(s) of Death: Cardiac death in cardiomyopathy
Copyright © 2022 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166